Carve-Out
Biosimilars, GLP-1s, and Stop-loss: Topics Benefit Advisors Need to Consider in Q3 2023
Don’t Ignore the Growing Specialty Medication Trend
Is Now the Right Time to Consider Self-Funding the Pharmacy Plan? – Part 2
Is Now the Right Time to Consider Self-Funding the Pharmacy Plan?
Does Your Specialty Rx Management Program Address Half Of Specialty Spend – Part 2
Is Your Specialty Rx Management Program Addressing Half Of Specialty Spend
It’s Time to Carve Out Pharmacy Benefits
Evaluating the Long-Term Carve-Out Savings Opportunity
Get Our Newsletter
Stay informed with expert advice and actionable insights to optimize pharmacy benefits, reduce costs and enhance member care.
